Aemetis and Edeniq, both headquartered in California (USA), announced they have entered into a definitive agreement under which Aemetis will acquire all of Edeniq’s outstanding shares in a stock plus cash merger transaction.
Edeniq, a leading cellulosic ethanol technology company, has developed patented innovations that unlock cellulosic and starch sugars through a combination of mechanical and biological processes. Its capital light and operationally efficient solutions can be easily integrated into existing corn ethanol plants. The company, founded in 2008, has raised approximately $100 million from some of the world’s leading venture capital firms, including Kleiner Perkins Caulfield & Byers, Draper Fisher Jurvetson, Angeleno Group, The Westly Group, I2BF Global Ventures, and other leading investors, as well as US Department of Energy (DOE) grant funding.
“The bioeconomy is the biggest chance we have to decarbonise our world and make it a more sustainable place”. Thomas Kläusli, Chief Marketing Officer at AVA Biochem and AVA-CO2, talks to Il Bioeconomista. AVA Biochem is a subsidiary of AVA-CO2 Schweiz AG, which produces the premium platform chemical 5-Hydroxymethylfurfural (5-HMF) from renewable biomass, and delivers to industrial and research customers around the globe. “5-HMF – the Swiss manager say – can be used for many applications, including the bioplastics industry”.
IL BIOECONOMISTA 